Zhang Xiao-juan, Luan Zheng-gang, Ma Xiao-chun
Department of Critical Care Medicine, the First Hospital, China Medical University, Shenyang 110001, Liaoning, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Sep;24(9):522-5.
To construct the short hairpin RNA (shRNA) targeting high mobility group box-1 (HMGB1) and culture the stable human umbilical vein endothelial cell (HUVEC) line expressing this shRNA.
Based on the HMGB1 gene sequence, shRNA was designed, synthesized and subcloned into the pRNA-u6.1/Neo vector, while negative controls were also established. Then the recombinant vector was transfected into HUVEC cell line and the cell was screened with G418 and assayed by using real time reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting.
Restriction endonuclease digestion test and sequencing verification showed that the recombinant pRNA-u6.1/Neo vector expressing this shRNA targeting HMGB1 was successfully constructed and the stable HUVEC cell line expressing this shRNA was developed. The real time RT-PCR and Western blotting was used to detect that recombinant plasmid in HUVEC cell effect on expression of HMGB1 was reduced. (mRNA: 0.4635 ± 0.0342 vs. 1.0340 ± 0.0352, protein: 0.4510 ± 0.0200 vs. 1.0210 ± 0.0110, both P<0.05).
The recombinant pRNA-u6.1/Neo vector expressing shRNA targeting HMGB1 was successfully constructed and the stable HUVEC cell line expressing this shRNA was developed, and therefore allowed further investigation regarding the function of HMGB1 gene in the HUVEC cell line.
构建靶向高迁移率族蛋白B1(HMGB1)的短发夹RNA(shRNA),并培养表达该shRNA的稳定人脐静脉内皮细胞(HUVEC)系。
根据HMGB1基因序列设计、合成shRNA并亚克隆至pRNA-u6.1/Neo载体,同时设立阴性对照。然后将重组载体转染至HUVEC细胞系,用G418筛选细胞,并通过实时逆转录-聚合酶链反应(RT-PCR)和蛋白质免疫印迹法进行检测。
限制性内切酶消化试验和测序验证表明,成功构建了表达靶向HMGB1的shRNA的重组pRNA-u6.1/Neo载体,并建立了表达该shRNA的稳定HUVEC细胞系。采用实时RT-PCR和蛋白质免疫印迹法检测发现,HUVEC细胞中的重组质粒对HMGB1表达的影响降低。(mRNA:0.4635±0.0342 vs. 1.0340±0.0352,蛋白质:0.4510±0.0200 vs. 1.0210±0.0110,均P<0.05)。
成功构建了表达靶向HMGB1的shRNA的重组pRNA-u6.1/Neo载体,并建立了表达该shRNA的稳定HUVEC细胞系,从而为进一步研究HMGB1基因在HUVEC细胞系中的功能奠定了基础。